Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$5,755,214
+$232,826 QoQ
Shares Held
22,661
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#1,514
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Claro Advisors Inc. holds $23,719,798 across 11 Drug Manufacturers - General names. JNJ ranks #2 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
23,282 | $5,858,682 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
22,661 | $5,755,214 | |
| 3 | LLY |
ELI LILLY & Co
|
3,896 | $4,672,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,805 | $1,516,942 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,313 | $1,400,915 | |
| 6 | AMGN |
Amgen Inc
|
3,385 | $1,225,776 | |
| 7 | PFE |
Pfizer Inc
|
47,000 | $1,131,760 | |
| 8 | NVO |
Novo Nordisk A S
|
21,612 | $1,036,079 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,755,214 | 22,661 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $5,522,388 | 22,592 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $4,474,052 | 21,619 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,945,552 | 21,279 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,257,088 | 21,323 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,978,501 | 23,990 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,130,010 | 21,643 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $4,044,045 | 24,954 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,310,816 | 22,652 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $3,698,324 | 23,379 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,422,261 | 21,834 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $3,579,135 | 22,980 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $4,113,668 | 24,853 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,802,555 | 18,081 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $3,244,707 | 18,368 | Shares | Sole | 2023-03-13 | |
| 2022-09-30 | $2,686,291 | 16,444 | Shares | Sole | 2022-11-18 | |
| 2022-06-30 | $2,918,974 | 16,444 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,709,846 | 15,290 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,615,660 | 15,290 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,395,368 | 14,832 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,383,458 | 14,468 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,315,527 | 14,089 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,157,994 | 13,712 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,056,181 | 13,811 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,941,678 | 13,807 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,763,042 | 13,445 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||